Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
Communications Biology|February 16, 2022
Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol effluxIdit Dotan, Jiaqi Yang, Jiro Ikeda, et al.
Atherosclerosis|June 2, 2026
Homozygous familial hypercholesterolemia (HoFH) in CanadaZobaida Al-Baldawi, Armen Erzingatzian, Isabelle Ruel, et al.
JACC. Advances|January 24, 2026
Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH RegistryArmen Erzingatzian, Zobaida Al-Baldawi, Isabelle Ruel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
A role for suppressed incisor cuspal morphogenesis in the evolution of mammalian heterodont dentitionAtsushi Ohazama, James Blackburn, Thantrira Porntaveetus, et al.
The Canadian Journal of Cardiology|December 12, 2018
Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018Liam R Brunham, Isabelle Ruel, Sumayah Aljenedil, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelRaul D Santos, Samuel S Gidding, Robert A Hegele, et al.
The New England Journal of Medicine|August 29, 2017
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseasePaul M Ridker, Brendan M Everett, Tom Thuren, et al.
The Canadian Journal of Cardiology|April 5, 2011
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group, Lawrence A Leiter, David H Fitchett, et al.
The Canadian Journal of Cardiology|April 5, 2011
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary), Lawrence A Leiter, David H Fitchett, et al.
American Journal of Human Genetics|August 5, 2008
WW-domain-containing oxidoreductase is associated with low plasma HDL-C levelsJenny C Lee, Daphna Weissglas-Volkov, Mira Kyttälä, et al.
Pageof 23